Amylgen - Preclinical CRO
  • Home
  • About Us
    • Our Team
    • Our Facilities
    • Our Partners
  • Services
    • Behavorial Analyses
    • PK/PD correlation
    • Biochemical & Immunochemistry analyses
    • Sigma 1 receptor agonist/antagonist properties in vitro
  • Models
    • Neurodegenerative Diseases
    • Brain Aging
    • Brain Development
    • Neuropsychiatric Diseases
    • Amnesia
  • Publications
  • News
  • Events
  • Contact
Newsletter
Neuroprotective effect of a new photobiomodulation technique against Aβ25–35 peptide–induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested
2018/02/19
3

Amylgen and Neuron-Experts Announce Exclusive, Strategic Partnership

20191210 PR Amylgen-NeuronExperts Partnership
Upload PDF (english version)
Upload PDF (french version)

ABOUT US

  • Our Team
  • Our Facilities
  • Our Partners

FOLLOW US

Legals© 2017 Amylgen. All Rights Reserved. Made by Ikada
    We use cookies to ensure you get the best experience on our website Find out more.